PureHealth Holding, a prominent healthcare group in the Middle East, has completed the acquisition of a 60% stake in Hellenic Healthcare Group (HHG), the leading private healthcare provider in Greece and Cyprus, for a total of €800 million ($939 million).
The deal values HHG at €1.3 billion on a 100% equity basis and represents a major step in PureHealth’s strategy to establish a globally integrated, innovation-driven healthcare platform based in Abu Dhabi.
Through this acquisition, PureHealth will incorporate HHG’s 11 hospitals and 23 diagnostic centres, extending healthcare services to more than 1.4 million patients each year.
Employing over 6,900 healthcare professionals, HHG now becomes a key component of PureHealth’s international network, further positioning Abu Dhabi as a global hub for healthcare excellence and investment.
A closing ceremony took place in Greece, attended by Kyriakos Pierrakakis, Greece’s Minister of National Economy and Finance; Adonis Georgiadis, Minister of Health; Dr Ali Obaid Ali Alyabhouni Aldhaheri, UAE Ambassador to Greece; and senior executives from PureHealth, CVC Capital Partners, and HHG.
Commenting on the transaction, Kamal Al Maazmi, Chairman of PureHealth, said: “Completing this deal is a pivotal milestone in our mission to build a globally connected healthcare platform. PureHealth has shown its ability to source opportunities, execute deals, and secure regulatory approvals in mature markets, demonstrating both our capabilities and international credibility.”
He added: “Through HHG, we are expanding into new geographies, enabling knowledge exchange, and fostering innovations that will enhance patient outcomes across our network. The acquisition was funded through PureHealth’s robust balance sheet, with financial benefits expected from October 1, 2025.”
Group CEO Shaista Asif stated: “Integrating HHG into our Group accelerates our vision of providing advanced, patient-focused healthcare across borders. This transaction strengthens clinical expertise, increases access to quality care, and diversifies revenue streams across mature markets and currencies.”
He continued: “It underscores our long-term dedication to creating value for patients, communities, and shareholders. Central to PureHealth’s growth is our AI-driven and expanding digital infrastructure, which transforms healthcare delivery globally. Leveraging top-tier talent and cutting-edge technology across our network allows us to build synergies and innovate across our platform.”
The HHG acquisition follows PureHealth’s recent global expansion, including the $1.2 billion purchase of the UK’s Circle Health Group in 2024 and a $500 million investment in US operator Ardent Health Services in 2022, which culminated in Ardent’s successful IPO on the New York Stock Exchange in 2024.
Together, these transactions illustrate PureHealth’s disciplined approach to acquiring high-quality assets and building a diversified, multi-geography portfolio across currencies.
